Related Experiment Video
Updated: Jul 13, 2026
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
What predicts mucosal inflammation in Crohn's disease patients?
Itta M Minderhoud1, Melvin Samsom, Bas Oldenburg
1Department of Gastroenterology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.
Insights
Current Crohn's disease (CD) activity indices lack reliability in predicting mucosal inflammation. A new, robust index is needed for accurate assessment of treatment response in clinical trials and practice.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- Over 30 years, numerous disease-specific instruments assess Crohn's disease (CD) activity.
- These indices use clinical and laboratory parameters, with their predictive roles reviewed extensively.
- Endoscopic assessment of mucosal inflammation is the current gold standard for CD activity.
Purpose of the Study:
- Critically appraise frequently used endoscopic indices for CD.
- Evaluate correlations between mucosal inflammation and clinical indices, quality of life, and biomarkers.
- Identify the need for improved disease activity assessment tools.
Main Methods:
- Review of existing literature on Crohn's disease activity indices.
- Analysis of correlations between endoscopic findings and clinical/laboratory/quality of life measures.
- Critical appraisal of the reliability and predictive value of current assessment tools.
Main Results:
- No single clinical disease activity index reliably predicts mucosal inflammation severity.
- Individual laboratory markers of inflammation are insufficient for accurate disease activity assessment.
- Existing indices show limited correlation with objective measures of mucosal healing.
Conclusions:
- Current clinical and laboratory indices do not accurately predict endoscopic disease activity in Crohn's disease.
- A novel, user-friendly, and validated index is essential for assessing treatment efficacy.
- Improved indices are crucial for drug development trials and clinical practice management.
Abstract:
A number of disease-specific instruments have been created over the last 30 years to assess disease activity in Crohn's disease (CD). These disease activity indices are constituted of clinical and laboratory parameters and their role in predicting disease activity and the course of disease has been reviewed various times. Currently, the severity of mucosal inflammation, assessed by endoscopy, is considered the gold standard for disease activity in CD. In the present review the most frequently used endoscopic disease activity indices and the correlation between mucosal inflammation and clinical disease activity indices, quality of life questionnaires, and biochemical markers is critically appraised. We conclude that no clinical disease activity index or single laboratory parameter of inflammation reliably predicts the mucosal inflammatory disease activity. A new, easy-to-use and robust activity index predicting mucosal inflammation is highly needed to assess the response to investigational drugs in trials and the effect of therapeutical interventions in clinical practice.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...